Albumin Mouse mAb - Primary antibody, specific to ALB, Mouse IgG2b

    Application:
  • ELISA
  • Flow Cytometry
  • IF/ICC
  • IHC
  • WB
Features and benefits
  • Host species: Mouse
  • Species reactivity(Reacts with): Human,Monkey
  • Isotype: Mouse IgG2b
  • Clone Number: 1F5H7
  • Conjugation: Unconjugated
Item Number
Ab087998
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab087998-10μl
10μl
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$69.90
Ab087998-50μl
50μl
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$210.90
Ab087998-100μl
100μl
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$357.90
Ab087998-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$3,225.90

mAb (1F5H7); Mouse anti Human Albumin Antibody; WB, IHC, ICC, IF, Flow, ELISA; Unconjugated

Basic Description

Product NameAlbumin Mouse mAb - Primary antibody, specific to ALB, Mouse IgG2b
SynonymsAlbumin antibody | alb antibody | ALBU_HUMAN antibody | Albumin (32 AA) antibody | Albumin (AA 34) antibody | cell growth inhibiting protein 42 antibody | DKFZp779N1935 antibody | GIG20 antibody | GIG42 antibody | Growth inhibiting protein 20 antibody | g
Specifications & PurityExactAb™, Validated, Carrier Free, 1.0mg/mL
Host speciesMouse
SpecificityALB
ImmunogenPurified recombinant fragment of human ALB (AA: 410-609) expressed in E.Coli.
Positive ControlWB: HepG2, HeLa, K562 lysates. ICC/IF: HeLa cells. IHC: Human bladder cancer tissue. Flow: HepG2 cells.
ConjugationUnconjugated
GradeCarrier Free, ExactAb™, Validated
Product Description

Mouse monoclonal (1F5H7) to ALB,could be used for WB, IHC, ICC, IF, Flow, ELISA.

Application:
WB: 1/500 - 1/2000
IHC: 1/200 - 1/1000
ICC/IF: 1/200 - 1/1000
Flow: 1/200 - 1/400
ELISA: 1/10000

Purity
Protein G purified

Function
Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.

Post-translational
Kenitra variant is partially O-glycosylated at Thr-620. It has two new disulfide bonds Cys-600 to Cys-602 and Cys-601 to Cys-606. Glycated in diabetic patients. Phosphorylation sites are present in the extracelllular medium. Acetylated on Lys-223 by acetylsalicylic acid.

Product Properties

IsotypeMouse IgG2b
Light Chain Typekappa
SDS-PAGE150kDa
Purification MethodProtein G purified
FormLiquid
Concentration1.0mg/mL
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageShipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C long term. Avoid repeated freeze / thaw cycles.

Associated Targets(Human)

ALB Tchem Serum albumin (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Application

ApplicationDilution info
WB1/500-1/2000

">

1/500-1/2000

IF/ICC

1/200 - 1/1000

Flow Cytometry

1/200-1/400

ELISA 1/10000

">

1/10000

IHC

1/200-1/1000

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
ZJ23F0700714Certificate of AnalysisJul 26, 2023 Ab087998
ZJ23F0700713Certificate of AnalysisJul 26, 2023 Ab087998

Related Documents

References

1. Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C et al..  (2003)  The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment..  Genome Res,  13  (10): (2265-70).  [PMID:12975309] [10.1021/op500134e]
2. Aston NM, Bamborough P, Buckton JB, Edwards CD, Holmes DS, Jones KL, Patel VK, Smee PA, Somers DO, Vitulli G et al..  (2009)  p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression..  J Med Chem,  52  (20): (6257-69).  [PMID:19772287] [10.1021/op500134e]
3. Lau J, Bloch P, Schäffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB et al..  (2015)  Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide..  J Med Chem,  58  (18): (7370-80).  [PMID:26308095] [10.1021/op500134e]
4. Kokkonda S, Deng X, White KL, El Mazouni F, White J, Shackleford DM, Katneni K, Chiu FCK, Barker H, McLaren J et al..  (2020)  Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria..  J Med Chem,  63  (9): (4929-4956).  [PMID:32248693] [10.1021/op500134e]
5. Cimitan S, Lindgren MT, Bertucci C, Danielson UH..  (2005)  Early absorption and distribution analysis of antitumor and anti-AIDS drugs: lipid membrane and plasma protein interactions..  J Med Chem,  48  (10): (3536-3546).  [PMID:15887962] [10.1021/jm049343o]
6. Wendt MD, Shen W, Kunzer A, McClellan WJ, Bruncko M, Oost TK, Ding H, Joseph MK, Zhang H, Nimmer PM, Ng SC, Shoemaker AR, Petros AM, Oleksijew A, Marsh K, Bauch J, Oltersdorf T, Belli BA, Martineau D, Fesik SW, Rosenberg SH, Elmore SW..  (2006)  Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivo..  J Med Chem,  49  (3): (1165-1181).  [PMID:16451081] [10.1021/jm050754u]
7. Ol'shevskaya VA, Nikitina RG, Savchenko AN, Malshakova MV, Vinogradov AM, Golovina GV, Belykh DV, Kutchin AV, Kaplan MA, Kalinin VN, Kuzmin VA, Shtil AA..  (2009)  Novel boronated chlorin e6-based photosensitizers: synthesis, binding to albumin and antitumour efficacy..  Bioorg Med Chem,  17  (3): (1297-1306).  [PMID:19121946] [10.1016/j.bmc.2008.12.016]
8. Wang YQ, Zhang HM, Zhou QH..  (2009)  Studies on the interaction of caffeine with bovine hemoglobin..  Eur J Med Chem,  44  (5): (2100-2105).  [PMID:19022538] [10.1016/j.ejmech.2008.10.010]
9. Chen L, Zhang Y, Sun X, Li H, LeSage G, Javer A, Zhang X, Wei X, Jiang Y, Yin D..  (2009)  Synthetic resveratrol aliphatic acid inhibits TLR2-mediated apoptosis and an involvement of Akt/GSK3beta pathway..  Bioorg Med Chem,  17  (13): (4378-4382).  [PMID:19477653] [10.1016/j.bmc.2009.05.029]
10. Kortylewicz ZP, Nearman J, Baranowska-Kortylewicz J..  (2009)  Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation..  J Med Chem,  52  (16): (5124-5143).  [PMID:19653647] [10.1021/jm9005803]
11. Zhang Y, Hays A, Noblett A, Thapa M, Hua DH, Hagenbuch B..  (2013)  Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives..  J Nat Prod,  76  (3): (368-373).  [PMID:23327877] [10.1021/np3007292]
12. Murugesan D, Mital A, Kaiser M, Shackleford DM, Morizzi J, Katneni K, Campbell M, Hudson A, Charman SA, Yeates C, Gilbert IH..  (2013)  Discovery and structure-activity relationships of pyrrolone antimalarials..  J Med Chem,  56  (7): (2975-2990).  [PMID:23517371] [10.1021/jm400009c]
13. Lorenz M, Evers A, Wagner M..  (2013)  Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity..  Bioorg Med Chem Lett,  23  (14): (4011-4018).  [PMID:23743288] [10.1016/j.bmcl.2013.05.022]
14. Gewald R, Grunwald C, Egerland U..  (2013)  Discovery of triazines as potent, selective and orally active PDE4 inhibitors..  Bioorg Med Chem Lett,  23  (15): (4308-4314).  [PMID:23806553] [10.1016/j.bmcl.2013.05.099]
15. Valhondo M, Marco I, Martín-Fontecha M, Vázquez-Villa H, Ramos JA, Berkels R, Lauterbach T, Benhamú B, López-Rodríguez ML..  (2013)  New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo..  J Med Chem,  56  (20): (7851-7861).  [PMID:24050112] [10.1021/jm400766k]
16. Wilson DM, Apps J, Bailey N, Bamford MJ, Beresford IJ, Brackenborough K, Briggs MA, Brough S, Calver AR, Crook B, Davis RK, Davis RP, Davis S, Dean DK, Harris L, Heslop T, Holland V, Jeffrey P, Panchal TA, Parr CA, Quashie N, Schogger J, Sehmi SS, Stean TO, Steadman JG, Trail B, Wald J, Worby A, Takle AK, Witherington J, Medhurst AD..  (2013)  Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists..  Bioorg Med Chem Lett,  23  (24): (6890-6896).  [PMID:24269482] [10.1016/j.bmcl.2013.09.090]
17. Skidmore J, Heer J, Johnson CN, Norton D, Redshaw S, Sweeting J, Hurst D, Cridland A, Vesey D, Wall I, Ahmed M, Rivers D, Myatt J, Giblin G, Philpott K, Kumar U, Stevens A, Bit RA, Haynes A, Taylor S, Watson R, Witherington J, Demont E, Heightman TD..  (2014)  Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles..  J Med Chem,  57  (24): (10424-10442).  [PMID:25431977] [10.1021/jm5010336]
18. Ishizuka T, Fujimori I, Nishida A, Sakurai H, Yoshigae Y, Nakahara K, Kurihara A, Ikeda T, Izumi T..  (2012)  Paraoxonase 1 as a major bioactivating hydrolase for olmesartan medoxomil in human blood circulation: molecular identification and contribution to plasma metabolism..  Drug Metab Dispos,  40  (2): (374-380).  [PMID:22086979] [10.1124/dmd.111.041475]
19. Visalli RJ, Ziobrowski H, Badri KR, He JJ, Zhang X, Arumugam SR, Zhao H..  (2015)  Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase..  Bioorg Med Chem Lett,  25  (16): (3168-3171).  [PMID:26112446] [10.1016/j.bmcl.2015.05.099]
20. Sekula B, Bujacz A..  (2016)  Structural Insights into the Competitive Binding of Diclofenac and Naproxen by Equine Serum Albumin..  J Med Chem,  59  (1): (82-89).  [PMID:26652101] [10.1021/acs.jmedchem.5b00909]
21. Rana S, Blowers EC, Tebbe C, Contreras JI, Radhakrishnan P, Kizhake S, Zhou T, Rajule RN, Arnst JL, Munkarah AR, Rattan R, Natarajan A..  (2016)  Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study..  J Med Chem,  59  (10): (5121-5127).  [PMID:27077228] [10.1021/acs.jmedchem.6b00400]
22. Ferla S, Bassetto M, Pertusati F, Kandil S, Westwell AD, Brancale A, McGuigan C..  (2016)  Rational design and synthesis of novel anti-prostate cancer agents bearing a 3,5-bis-trifluoromethylphenyl moiety..  Bioorg Med Chem Lett,  26  (15): (3636-3640).  [PMID:27301368] [10.1016/j.bmcl.2016.06.001]
23. Simões CJV, Almeida ZL, Costa D, Jesus CSH, Cardoso AL, Almeida MR, Saraiva MJ, Pinho E Melo TMVD, Brito RMM..  (2016)  A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition..  Eur J Med Chem,  121  (823-840).  [PMID:27020050] [10.1016/j.ejmech.2016.02.074]
24. Zheng Z, Pinson JA, Mountford SJ, Orive S, Schoenwaelder SM, Shackleford D, Powell A, Nelson EM, Hamilton JR, Jackson SP, Jennings IG, Thompson PE..  (2016)  Discovery and antiplatelet activity of a selective PI3Kβ inhibitor (MIPS-9922)..  Eur J Med Chem,  122  (339-351).  [PMID:27387421] [10.1016/j.ejmech.2016.06.010]
25. Cocco M, Pellegrini C, Martínez-Banaclocha H, Giorgis M, Marini E, Costale A, Miglio G, Fornai M, Antonioli L, López-Castejón G, Tapia-Abellán A, Angosto D, Hafner-Bratkovič I, Regazzoni L, Blandizzi C, Pelegrín P, Bertinaria M..  (2017)  Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease..  J Med Chem,  60  (9): (3656-3671).  [PMID:28410442] [10.1021/acs.jmedchem.6b01624]
26. Konstantinović J, Kiris E, Kota KP, Kugelman-Tonos J, Videnović M, Cazares LH, Terzić Jovanović N, Verbić TŽ, Andjelković B, Duplantier AJ, Bavari S, Šolaja BA..  (2018)  New Steroidal 4-Aminoquinolines Antagonize Botulinum Neurotoxin Serotype A in Mouse Embryonic Stem Cell Derived Motor Neurons in Postintoxication Model..  J Med Chem,  61  (4): (1595-1608).  [PMID:29385334] [10.1021/acs.jmedchem.7b01710]
27. Bharate SB, Kumar V, Jain SK, Mintoo MJ, Guru SK, Nuthakki VK, Sharma M, Bharate SS, Gandhi SG, Mondhe DM, Bhushan S, Vishwakarma RA..  (2018)  Discovery and Preclinical Development of IIIM-290, an Orally Active Potent Cyclin-Dependent Kinase Inhibitor..  J Med Chem,  61  (4): (1664-1687).  [PMID:29370702] [10.1021/acs.jmedchem.7b01765]
28. Walker AL, Ancellin N, Beaufils B, Bergeal M, Binnie M, Bouillot A, Clapham D, Denis A, Haslam CP, Holmes DS, Hutchinson JP, Liddle J, McBride A, Mirguet O, Mowat CG, Rowland P, Tiberghien N, Trottet L, Uings I, Webster SP, Zheng X, Mole DJ..  (2017)  Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis..  J Med Chem,  60  (8): (3383-3404).  [PMID:28398044] [10.1021/acs.jmedchem.7b00055]
29. Pedron J, Boudot C, Hutter S, Bourgeade-Delmas S, Stigliani JL, Sournia-Saquet A, Moreau A, Boutet-Robinet E, Paloque L, Mothes E, Laget M, Vendier L, Pratviel G, Wyllie S, Fairlamb A, Azas N, Courtioux B, Valentin A, Verhaeghe P..  (2018)  Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study..  Eur J Med Chem,  155  (135-152).  [PMID:29885575] [10.1016/j.ejmech.2018.06.001]
30. Miller M, Pal A, Albusairi W, Joo H, Pappas B, Haque Tuhin MT, Liang D, Jampala R, Liu F, Khan J, Faaij M, Park M, Chan W, Graef I, Zamboni R, Kumar N, Fox J, Sinha U, Alhamadsheh M..  (2018)  Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis..  J Med Chem,  61  (17): (7862-7876).  [PMID:30133284] [10.1021/acs.jmedchem.8b00817]
31. Nair RR, Geldenhuys WJ, Piktel D, Sadana P, Gibson LF..  (2018)  Novel compounds that target lipoprotein lipase and mediate growth arrest in acute lymphoblastic leukemia..  Bioorg Med Chem Lett,  28  (10): (1937-1942).  [PMID:29650292] [10.1016/j.bmcl.2018.03.061]
32. Cai X, Sun L, Dai Y, Avraham Y, Liu C, Han J, Liu Y, Feng D, Huang W, Qian H..  (2018)  Novel fatty acid chain modified GLP-1 derivatives with prolonged in vivo glucose-lowering ability and balanced glucoregulatory activity..  Bioorg Med Chem,  26  (9): (2599-2609).  [PMID:29673717] [10.1016/j.bmc.2018.04.022]
33. Odagiri T, Inagaki H, Nagamochi M, Kitamura T, Komoriya S, Takahashi H..  (2018)  Design, Synthesis, and Biological Evaluation of Novel 7-[(3 aS,7 aS)-3 a-Aminohexahydropyrano[3,4- c]pyrrol-2(3 H)-yl]-8-methoxyquinolines with Potent Antibacterial Activity against Respiratory Pathogens..  J Med Chem,  61  (16): (7234-7244).  [PMID:30063826] [10.1021/acs.jmedchem.8b00644]
34. Tassini S, Langron E, Delang L, Mirabelli C, Lanko K, Crespan E, Kissova M, Tagliavini G, Fontò G, Bertoni S, Palese S, Giorgio C, Ravanetti F, Ragionieri L, Zamperini C, Mancini A, Dreassi E, Maga G, Vergani P, Neyts J, Radi M..  (2019)  Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †..  J Med Chem,  62  (23): (10833-10847).  [PMID:31729878] [10.1021/acs.jmedchem.9b01416]
35. Xu X, Kuang Z, Han J, Meng Y, Li L, Luan H, Xu P, Wang J, Luo C, Ding H, Li Z, Bian J..  (2019)  Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors..  J Med Chem,  62  (21): (9642-9657).  [PMID:31603674] [10.1021/acs.jmedchem.9b01035]
36. Pedron J, Boudot C, Brossas JY, Pinault E, Bourgeade-Delmas S, Sournia-Saquet A, Boutet-Robinet E, Destere A, Tronnet A, Bergé J, Bonduelle C, Deraeve C, Pratviel G, Stigliani JL, Paris L, Mazier D, Corvaisier S, Since M, Malzert-Fréon A, Wyllie S, Milne R, Fairlamb AH, Valentin A, Courtioux B, Verhaeghe P..  (2020)  New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruzi..  ACS Med Chem Lett,  11  (4): (464-472).  [PMID:32292551] [10.1021/acsmedchemlett.9b00566]
37. Marín-Ramos NI, Balabasquer M, Ortega-Nogales FJ, Torrecillas IR, Gil-Ordóñez A, Marcos-Ramiro B, Aguilar-Garrido P, Cushman I, Romero A, Medrano FJ, Gajate C, Mollinedo F, Philips MR, Campillo M, Gallardo M, Martín-Fontecha M, López-Rodríguez ML, Ortega-Gutiérrez S..  (2019)  A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor Improves Survival in Ras-Driven Acute Myeloid Leukemia..  J Med Chem,  62  (13): (6035-6046).  [PMID:31181882] [10.1021/acs.jmedchem.9b00145]
38. Renoux B, Fangous L, Hötten C, Péraudeau E, Eddhif B, Poinot P, Clarhaut J, Papot S..  (2018)  A β-glucuronidase-responsive albumin-binding prodrug programmed for the double release of monomethyl auristatin E..  Medchemcomm,  (12): (2068-2071).  [PMID:30746064] [10.1039/C8MD00466H]
39. Sensfuss U, Kruse T, Skyggebjerg RB, Uldam HK, Vestergaard B, Huus K, Vinther TN, Reinau ME, Schéele S, Clausen TR..  (2019)  Structure-Activity Relationships and Characterization of Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor Agonists..  J Med Chem,  62  (3): (1407-1419).  [PMID:30624060] [10.1021/acs.jmedchem.8b01558]
40. Aneja B, Khan NS, Khan P, Queen A, Hussain A, Rehman MT, Alajmi MF, El-Seedi HR, Ali S, Hassan MI, Abid M..  (2019)  Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis..  Eur J Med Chem,  163  (840-852).  [PMID:30579124] [10.1016/j.ejmech.2018.12.026]
41. Morales P, Gómez-Cañas M, Navarro G, Hurst DP, Carrillo-Salinas FJ, Lagartera L, Pazos R, Goya P, Reggio PH, Guaza C, Franco R, Fernández-Ruiz J, Jagerovic N..  (2016)  Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis..  J Med Chem,  59  (14): (6753-6771).  [PMID:27309150] [10.1021/acs.jmedchem.6b00397]
42. Aneja B, Queen A, Khan P, Shamsi F, Hussain A, Hasan P, Rizvi MMA, Daniliuc CG, Alajmi MF, Mohsin M, Hassan MI, Abid M..  (2020)  Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX..  Bioorg Med Chem,  28  (9): (115424-115424).  [PMID:32209296] [10.1016/j.bmc.2020.115424]
43. Singh I,Rani R,Luxami V,Paul K.  (2019)  Synthesis of 5-(4-(1H-phenanthro[9,10-d]imidazol-2-yl)benzylidene)thiazolidine-2,4-dione as promising DNA and serum albumin-binding agents and evaluation of antitumor activity..  Eur J Med Chem,  166  (267-280).  [PMID:30721822] [10.1016/j.ejmech.2019.01.053]
44. Pellicciari R,Passeri D,De Franco F,Mostarda S,Filipponi P,Colliva C,Gadaleta RM,Franco P,Carotti A,Macchiarulo A,Roda A,Moschetta A,Gioiello A.  (2016)  Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders..  J Med Chem,  59  (19): (9201-9214).  [PMID:27652492] [10.1021/acs.jmedchem.6b01126]
45. Wang C,Zhao Q,Vargas M,Jones JO,White KL,Shackleford DM,Chen G,Saunders J,Ng AC,Chiu FC,Dong Y,Charman SA,Keiser J,Vennerstrom JL.  (2016)  Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978)..  J Med Chem,  59  (23): (10705-10718).  [PMID:27933964] [10.1021/acs.jmedchem.6b01410]
46. Chen X,Fu J,Zhou F,Yang Q,Wang J,Feng H,Jiang W,Jin L,Tang X,Jiang N,Yin J,Han J.  (2020)  Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes..  J Med Chem,  63  (21): (12595-12613).  [PMID:33125843] [10.1021/acs.jmedchem.0c00736]
47. Han J,Fu J,Yang Q,Zhou F,Chen X,Li C,Yin J.  (2020)  Rational design and biological evaluation of gemfibrozil modified Xenopus GLP-1 derivatives as long-acting hypoglycemic agents..  Eur J Med Chem,  198  (112389-112389).  [PMID:32388115] [10.1016/j.ejmech.2020.112389]
48. Lacivita E,Niso M,Stama ML,Arzuaga A,Altamura C,Costa L,Desaphy JF,Ragozzino ME,Ciranna L,Leopoldo M.  (2020)  Privileged scaffold-based design to identify a novel drug-like 5-HT receptor-preferring agonist to target Fragile X syndrome..  Eur J Med Chem,  199  (112395-112395).  [PMID:32442850] [10.1016/j.ejmech.2020.112395]
49. and Jacobsen, C C..  (1978)  Lysine residue 240 of human serum albumin is involved in high-affinity binding of bilirubin..  The Biochemical journal,    (1):   [PMID:656055]
50. and Walker, J E JE..  (1976)  Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid..  FEBS letters,    (15):   [PMID:955075]
51. Meloun, B B, Morávek, L L and Kostka, V V..  (1975)  Complete amino acid sequence of human serum albumin..  FEBS letters,    (15):   [PMID:1225573]
52. Minchiotti, L L and 6 more authors..  (1992)  Two alloalbumins with identical electrophoretic mobility are produced by differently charged amino acid substitutions..  Biochimica et biophysica acta,    (12):   [PMID:1347703]
53. Carlson, J J and 5 more authors..  (1992)  Alloalbuminemia in Sweden: structural study and phenotypic distribution of nine albumin variants..  Proceedings of the National Academy of Sciences of the United States of America,    (1):   [PMID:1518850]
54. He, X M XM and Carter, D C DC..  (1992)  Atomic structure and chemistry of human serum albumin..  Nature,    (16):   [PMID:1630489]
55. Peach, R J RJ and Brennan, S O SO..  (1991)  Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp----Asn)..  Biochimica et biophysica acta,    (26):   [PMID:1859851]
56. Madison, J J and 9 more authors..  (1991)  Genetic variants of serum albumin in Americans and Japanese..  Proceedings of the National Academy of Sciences of the United States of America,    (1):   [PMID:1946412]
57. Watkins, S S and 6 more authors..  (1991)  A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin..  Proceedings of the National Academy of Sciences of the United States of America,    (15):   [PMID:2068071]
58. Brennan, S O SO, Myles, T T, Peach, R J RJ, Donaldson, D D and George, P M PM..  (1990)  Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:2104980]
59. Galliano, M M and 7 more authors..  (1990)  Mutations in genetic variants of human serum albumin found in Italy..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:2247440]
60. Carter, D C DC and He, X M XM..  (1990)  Structure of human serum albumin..  Science (New York, N.Y.),    (20):   [PMID:2374930]
61. Arai, K K, Madison, J J, Shimizu, A A and Putnam, F W FW..  (1990)  Point substitutions in albumin genetic variants from Asia..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:2404284]
62. Urano, Y Y, Watanabe, K K, Sakai, M M and Tamaoki, T T..  (1986)  The human albumin gene. Characterization of the 5' and 3' flanking regions and the polymorphic gene transcripts..  The Journal of biological chemistry,    (5):   [PMID:2419329]
63. Carraway, R E RE, Mitra, S P SP and Cochrane, D E DE..  (1987)  Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s)..  The Journal of biological chemistry,    (5):   [PMID:2437111]
64. Carter, D C DC and 6 more authors..  (1989)  Three-dimensional structure of human serum albumin..  Science (New York, N.Y.),    (9):   [PMID:2727704]
65. Arai, K K and 8 more authors..  (1989)  Point substitutions in Japanese alloalbumins..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:2762316]
66. Arai, K K, Ishioka, N N, Huss, K K, Madison, J J and Putnam, F W FW..  (1989)  Identical structural changes in inherited albumin variants from different populations..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:2911589]
67. Minghetti, P P PP and 6 more authors..  (1986)  Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4..  The Journal of biological chemistry,    (25):   [PMID:3009475]
68. Mogard, M H MH and 6 more authors..  (1986)  The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin..  Biochemical and biophysical research communications,    (14):   [PMID:3087352]
69. Takahashi, N N, Takahashi, Y Y, Blumberg, B S BS and Putnam, F W FW..  (1987)  Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:3474609]
70. Takahashi, N N and 6 more authors..  (1987)  Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:3479777]
71. Iberg, N N and Flückiger, R R..  (1986)  Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites..  The Journal of biological chemistry,    (15):   [PMID:3759977]
72. Brennan, S O SO and Herbert, P P..  (1987)  Albumin Canterbury (313 Lys----Asn). A point mutation in the second domain of serum albumin..  Biochimica et biophysica acta,    (8):   [PMID:3828358]
73. Lawn, R M RM and 7 more authors..  (1981)  The sequence of human serum albumin cDNA and its expression in E. coli..  Nucleic acids research,    (25):   [PMID:6171778]
74. Dugaiczyk, A A, Law, S W SW and Dennison, O E OE..  (1982)  Nucleotide sequence and the encoded amino acids of human serum albumin mRNA..  Proceedings of the National Academy of Sciences of the United States of America,      [PMID:6275391]
75. Rushbrook, J I JI, Becker, E E, Schussler, G C GC and Divino, C M CM..  (1995)  Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia..  The Journal of clinical endocrinology and metabolism,      [PMID:7852505]
76. Corbett, J M JM, Wheeler, C H CH, Baker, C S CS, Yacoub, M H MH and Dunn, M J MJ..  (1994)  The human myocardial two-dimensional gel protein database: update 1994..  Electrophoresis,      [PMID:7895732]
77. Galliano, M M and 7 more authors..  (1993)  Protein and DNA sequence analysis of a 'private' genetic variant: albumin Ortonovo (Glu-505-->Lys)..  Biochimica et biophysica acta,    (25):   [PMID:7902134]
78. Madison, J J and 6 more authors..  (1994)  Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant..  Proceedings of the National Academy of Sciences of the United States of America,    (5):   [PMID:8022807]
79. Sunthornthepvarakul, T T, Angkeow, P P, Weiss, R E RE, Hayashi, Y Y and Refetoff, S S..  (1994)  An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families..  Biochemical and biophysical research communications,    (29):   [PMID:8048949]
80. Watkins, S S, Madison, J J, Galliano, M M, Minchiotti, L L and Putnam, F W FW..  (1994)  A nucleotide insertion and frameshift cause analbuminemia in an Italian family..  Proceedings of the National Academy of Sciences of the United States of America,    (15):   [PMID:8134387]
81. Brennan, S O SO and Fellowes, A P AP..  (1993)  Albumin Hawkes Bay; a low level variant caused by loss of a sulphydryl group at position 177..  Biochimica et biophysica acta,    (4):   [PMID:8347685]
82. Minchiotti, L L, Galliano, M M, Zapponi, M C MC and Tenni, R R..  (1993)  The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240-->Glu] albumin mutant..  European journal of biochemistry,    (1):   [PMID:8513793]
83. Berggård, T T, Thelin, N N, Falkenberg, C C, Enghild, J J JJ and Akerström, B B..  (1997)  Prothrombin, albumin and immunoglobulin A form covalent complexes with alpha1-microglobulin in human plasma..  European journal of biochemistry,    (1):   [PMID:9183005]
84. Wada, N N and 5 more authors..  (1997)  A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred..  The Journal of clinical endocrinology and metabolism,      [PMID:9329347]
85. Sunthornthepvarakul, T T and 6 more authors..  (1998)  Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly inherited albumin defect..  The Journal of clinical endocrinology and metabolism,      [PMID:9589637]
86. Curry, S S, Mandelkow, H H, Brick, P P and Franks, N N..  (1998)  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites..  Nature structural biology,      [PMID:9731778]
87. Sugio, S S, Kashima, A A, Mochizuki, S S, Noda, M M and Kobayashi, K K..  (1999)  Crystal structure of human serum albumin at 2.5 A resolution..  Protein engineering,      [PMID:10388840]
88. Bhattacharya, A A AA, Curry, S S and Franks, N P NP..  (2000)  Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures..  The Journal of biological chemistry,    (8):   [PMID:10940303]
89. Minchiotti, L L and 10 more authors..  (2001)  A nucleotide insertion and frameshift cause albumin Kénitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges..  European journal of biochemistry,      [PMID:11168369]
90. Yu, Y Y and 16 more authors..  (2001)  Gene expression profiling in human fetal liver and identification of tissue- and developmental-stage-specific genes through compiled expression profiles and efficient cloning of full-length cDNAs..  Genome research,      [PMID:11483580]
91. Spahr, C S CS and 12 more authors..  (2001)  Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest..  Proteomics,      [PMID:11680902]
92. Gevaert, Kris K and 6 more authors..  (2003)  Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides..  Nature biotechnology,      [PMID:12665801]
93. Hillier, Ladeana W LW and 121 more authors..  (2005)  Generation and annotation of the DNA sequences of human chromosomes 2 and 4..  Nature,    (7):   [PMID:15815621]
94. Bechtel, Stephanie S and 18 more authors..  (2007)  The full-ORF clone resource of the German cDNA Consortium..  BMC genomics,    (31):   [PMID:17974005]
95. Han, Guanghui G and 9 more authors..  (2008)  Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography..  Proteomics,      [PMID:18318008]
96. Mayya, Viveka V and 7 more authors..  (2009)  Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions..  Science signaling,    (18):   [PMID:19690332]
97. and Lansdown, Alan B G..  (2010)  A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices..  Advances in pharmacological sciences,      [PMID:21188244]
98. Veerappan, Anbazhagan A, Eichhorn, Tolga T, Zeino, Maen M, Efferth, Thomas T and Schneider, Dirk D..  (2013)  Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin..  Phytomedicine : international journal of phytotherapy and phytopharmacology,    (15):   [PMID:23684544]
99. Guo, Ailan and 15 more authors..  (2014)  Immunoaffinity enrichment and mass spectrometry analysis of protein methylation..  Molecular & cellular proteomics : MCP,      [PMID:24129315]
100. Bian, Yangyang Y and 9 more authors..  (2014)  An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome..  Journal of proteomics,    (16):   [PMID:24275569]
101. Tagliabracci, Vincent S VS and 14 more authors..  (2015)  A Single Kinase Generates the Majority of the Secreted Phosphoproteome..  Cell,    (18):   [PMID:26091039]
102. Thomas R Burkard,Melanie Planyavsky,Ines Kaupe,Florian P Breitwieser,Tilmann Bürckstümmer,Keiryn L Bennett,Giulio Superti-Furga,Jacques Colinge.  (2011-01-29)  Initial characterization of the human central proteome..  BMC systems biology,  (17-17).  [PMID:21269460]

Solution Calculators